• 11789 Citations
  • 53 h-Index
1980 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

Filter
Comment/debate
2017

The Use of Antiangiogenic Agents for Lung Cancer in Elderly Patients: An Expert Panel Discussion Synopsis

Socinski, M. A., Chaft, J. E., Levy, B., Riely, G. J., Langer, C. J., Perez-Soler, R., Middleton, D. L., Gracie-King, L. & Healy, L. M., May 2017, In : Clinical lung cancer. 18, 3, p. 255-258 4 p.

Research output: Contribution to journalComment/debate

2 Scopus citations
1 Scopus citations
2010

EGFR TKIs for advanced NSCLC: Practical questions

Perez-Soler, R., May 2010, In : ONCOLOGY. 24, 5

Research output: Contribution to journalComment/debate

2 Scopus citations
2008

Erratum: PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab. (Cancer Res (2008) 68 (1953-61))

Jhawer, M., Goel, S., Wilson, A. J., Montagna, C., Ling, Y. H., Byun, D. S., Nasser, S., Arango, D., Shin, J., Klampfer, L., Augenlicht, L. H., Perez-Soler, R. & Mariadason, J. M., Aug 15 2008, In : Cancer Research. 68, 16, 1 p.

Research output: Contribution to journalComment/debate

1997

Topotecan: Expanding its efficacy beyond ovarian cancer

Perez-Soler, R., Dec 1 1997, In : Seminars in Oncology. 24, 6 SUPPL. 20, p. S201-S202

Research output: Contribution to journalComment/debate